# Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

Article · Lukas Franz Mager, Regula Burkhard, Nicola Pett, Noah C.A. Cooke, Kirsty Brown, Hena R. Ramay, Seungil Paik, John Stagg, Ryan A. Groves, Marco Gallo, Ian A. Lewis, Markus B. Geuking, Kathy D. McCoy

- Archive id: doi:10.1126/science.abc3421
- Published: 2020-08-13
- Venue: Science
- DOI: https://doi.org/10.1126/science.abc3421
- PMID: 32792462
- Citations: 1,405
- Source URL: https://doi.org/10.1126/science.abc3421
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

Cited in dossiers:
- [Cancer Immunotherapy: State of the Field (October 2026)](https://space-kitty.com/dossiers/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.